Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cyclosporine ophthalmic emulsion 0.05% not only alleviates the symptoms of dry eye disease but also prevents its progression, according to the results of a recent study. Patients who have moderate to severe dry eye disease particularly can benefit from the topical application of anti–inflammatory medications such as cyclosporine because artificial tears and other treatments often are inadequate in this patient population, according to one ophthalmologist.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address